Clinical Operational Research Unit, Department of Mathematics, University College London, London, UK.
Thorax. 2012 Feb;67(2):185-7. doi: 10.1136/thoraxjnl-2011-200015. Epub 2011 May 10.
PulMiCC (Pulmonary Metastasectomy in Colorectal Cancer) is a randomised controlled trial funded by Cancer Research UK. Patients with a history of resected colorectal cancer who are found to have pulmonary metastases are first registered for evaluation and, if subsequently eligible for the trial, they are invited to be randomly allocated to 'active monitoring' or 'active monitoring with pulmonary metastasectomy'. The clinical outcomes are overall survival, relapse-free survival, lung function and patient-reported quality of life.
PulMiCC(结直肠癌肺转移切除术)是由英国癌症研究中心资助的一项随机对照试验。有结直肠癌病史且发现有肺转移的患者首先进行评估登记,如果符合试验条件,他们将被邀请随机分配到“主动监测”或“主动监测加肺转移切除术”组。主要临床结局包括总生存期、无复发生存期、肺功能和患者报告的生活质量。